Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies



Rating:

Share or cite this content

Citations should be made in the following way:
P. Jones (Brentford, United Kingdom), S. Shukla (Collegeville, United States of America), L. Tombs (London, United Kingdom), A. Ismaila (Collegeville, United States of America), A. Martin (Uxbridge, United Kingdom), D. Midwinter (Brentford, United Kingdom), I. Boucot (Brentford, United Kingdom), N. Risebrough (Toronto, Canada), C. Vogelmeier (Marburg, Germany). Predicting SGRQ score based on CAT score: post-hoc analysis of the IMPACT trial. 794

Member's Comments

No comment yet.

Related content which might interest you: Comparison of individual items of COPD Assessment Test (CAT) at baseline in the EMAX and IMPACT trials Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Impact of grouping patients by 2017 GOLD strategy assessment criteria: a post hoc analysis of the TONADO and OTEMTO trials Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 COPD Assessment Test (CAT) scores following a digital health intervention Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Validation of the SGRQ-I derived from SGRQ Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Time dependent changes in the individual domains of the SGRQ. Results of the TORCH trial Source: Eur Respir J 2007; 30: Suppl. 51, 609s Year: 2007 Assessing asthma control using a composite measure based on GINA/NIH guidelines: an analysis of GOAL baseline data Source: Eur Respir J 2002; 20: Suppl. 38, 47s Year: 2002 ICS withdrawal and exacerbation risk by GOLD 2017 Report: post hoc analysis of the WISDOM trial Source: International Congress 2018 – Primary care management of respiratory conditions Year: 2018 Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study Source: ERJ Open Res, 5 (1) 00243-2018; 10.1183/23120541.00243-2018 Year: 2019 Comparison of scores from a 40-item version of the SGRQ with the original version Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005 Are the mMRC dyspnea scale of 2 and a CAT score of 10 equivalent as proposed by the GOLD strategy? Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Symptom improvement over time with umeclidinium/vilanterol versus monotherapy: a post-hoc analysis of the EMAX trial Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Comparability of Asthma Control Test (ACT) scores between self and physician administered test. Source: International Congress 2018 – Asthma: clinical screening tools Year: 2018 Assessment of health status using CAT scores in COPD patients from Italy: the MISTRAL study Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Clinical COPD questionnaire (CCQ) score and mortality Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Determinants of the relationship between changes in FEV1 and SGRQ: analysis of the TORCH data Source: Annual Congress 2008 - COPD Year: 2008 Use of the modified Borg scale and numerical rating scale to measure chronic breathlessness: a pooled data analysis Source: Eur Respir J 2016; 47:1861-1864 Year: 2016 BODE is better associated with quality of life (QoL) than GOLD: data from the INTERCOM trial Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005 Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Effect of interval training on the BODE index, SF-36, EuroQol and St-George‘s Respiratory Questionnaires scores in COPD patients across GOLD stages I-IV Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020